{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:51:17Z","timestamp":1781837477901,"version":"3.54.5"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/00977-0"],"award-info":[{"award-number":["2015\/00977-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50023-1","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:15:48Z","timestamp":1777119348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Residual bile flow shapes PPAR\u03b3-mediated antifibrotic responses in experimental segmental cholestasis"],"prefix":"10.1038","volume":"16","author":[{"given":"Josiane O.","family":"Gon\u00e7alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleiton A. M.","family":"Mafra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isac","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Cogliati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Y.","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walcy R.","family":"Teodoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suellen","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo F.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Moreira-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uenis","family":"Tannuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C. A.","family":"Tannuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"50023_CR1","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","volume":"90","author":"KN Lazaridis","year":"2015","unstructured":"Lazaridis, K. N. & LaRusso, N. F. The cholangiopathies. Mayo Clin. Proc. 90, 791\u2013800 (2015).","journal-title":"Mayo Clin. Proc."},{"key":"50023_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1477-2574.2012.00481.x","volume":"14","author":"D Yeo","year":"2012","unstructured":"Yeo, D., Perini, M. V., Muralidharan, V. & Christophi, C. Focal intrahepatic strictures: A review of diagnosis and management. HPB 14, 425\u2013434 (2012).","journal-title":"HPB"},{"key":"50023_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-1","volume":"3","author":"T Kumagi","year":"2008","unstructured":"Kumagi, T. & Heathcote, Ej. . Primary biliary cirrhosis. Orphanet J. Rare Dis. 3, 1 (2008).","journal-title":"Orphanet J. Rare Dis."},{"key":"50023_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fmed.2020.00149","volume":"7","author":"A Kriegermeier","year":"2020","unstructured":"Kriegermeier, A. & Green, R. Pediatric cholestatic liver disease: review of bile acid metabolism and discussion of current and emerging therapies. Front. Med. 7, 149 (2020).","journal-title":"Front. Med."},{"key":"50023_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ebiom.2018.08.024","volume":"35","author":"PKH Tam","year":"2018","unstructured":"Tam, P. K. H., Yiu, R. S., Lendahl, U. & Andersson, E. R. Cholangiopathies \u2013 Towards a molecular understanding. EBioMedicine 35, 381\u2013393 (2018).","journal-title":"EBioMedicine"},{"key":"50023_CR6","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/hep.29905","volume":"68","author":"JA Bezerra","year":"2018","unstructured":"Bezerra, J. A. et al. Biliary atresia: clinical and research challenges for the twenty-first century. Hepatology 68, 1163\u20131173 (2018).","journal-title":"Hepatology"},{"key":"50023_CR7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/joim.13028","volume":"287","author":"H Johansson","year":"2020","unstructured":"Johansson, H. et al. Regulation of bile acid metabolism in biliary atresia: Reduction of FGF19 by Kasai portoenterostomy and possible relation to early outcome. J. Intern. Med. 287, 534\u2013545 (2020).","journal-title":"J. Intern. Med."},{"key":"50023_CR8","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jhep.2019.02.003","volume":"70","author":"R Manco","year":"2019","unstructured":"Manco, R. et al. Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury. J. Hepatol. 70, 1180\u20131191 (2019).","journal-title":"J. Hepatol."},{"key":"50023_CR9","first-page":"1192840","volume":"14","author":"X Cai","year":"2023","unstructured":"Cai, X., Tacke, F., Guillot, A. & Liu, H. Cholangiokines undervalued modulators in the hepatic microenvironment front. Immunol. 14, 1192840 (2023).","journal-title":"Immunol."},{"key":"50023_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41467-025-56024-4","volume":"16","author":"R A Mart\u00ednezGarc\u00eda de la Torre,","year":"2025","unstructured":"Mart\u00ednezGarc\u00eda de la Torre, R. A. et al. Trajectory analysis of hepatic stellate cell differentiation reveals metabolic regulation of cell commitment and fibrosis. Nat. Commun. 16, 1489 (2025).","journal-title":"Nat. Commun."},{"key":"50023_CR11","doi-asserted-by":"crossref","unstructured":"Mao, X. et al. From mechanisms to anti-fibrotic drugs in hepatic stellate cell research: a global bibliometric analysis with patent and clinical perspectives (2000\u20132025). Front. Pharmacol. 16 (2025).","DOI":"10.3389\/fphar.2025.1734449"},{"key":"50023_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00821-z","author":"B Cogliati","year":"2023","unstructured":"Cogliati, B., Yashaswini, C. N., Wang, S., Sia, D. & Friedman, S. L. Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nat. Rev. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1038\/s41575-023-00821-z (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"50023_CR13","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41586-025-08677-w","volume":"640","author":"A Sugimoto","year":"2025","unstructured":"Sugimoto, A. et al. Hepatic stellate cells control liver zonation, size and functions via R-spondin 3. Nature 640, 752\u2013761 (2025).","journal-title":"Nature"},{"key":"50023_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ph18040507","volume":"18","author":"H Xiong","year":"2025","unstructured":"Xiong, H. & Guo, J. Targeting hepatic stellate cells for the prevention and treatment of liver cirrhosis and hepatocellular carcinoma: strategies and clinical translation. Pharmaceuticals 18, 507 (2025).","journal-title":"Pharmaceuticals"},{"key":"50023_CR15","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2026.5733","volume":"57","author":"C Gao","year":"2026","unstructured":"Gao, C. et al. Beyond hepatic stellate cell heterogeneity: resolving fibrosis, restoring regeneration (Review). Int. J. Mol. Med. 57, 62 (2026).","journal-title":"Int. J. Mol. Med."},{"key":"50023_CR16","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2023.05.043","volume":"79","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. GARP on hepatic stellate cells is essential for the development of liver fibrosis. J. Hepatol. 79, 1214\u20131225 (2023).","journal-title":"J. Hepatol."},{"key":"50023_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/MEG.0000000000001649","volume":"32","author":"T Zhou","year":"2020","unstructured":"Zhou, T. et al. Intrahepatic biliary strictures after liver transplantation are morphologically similar to primary sclerosing cholangitis but immunologically distinct. Eur. J. Gastroenterol. Hepatol. 32, 276\u2013284 (2020).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"50023_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5009\/gnl.2011.5.2.133","volume":"5","author":"CH Ryu","year":"2011","unstructured":"Ryu, C. H. & Lee, S. K. Biliary strictures after liver transplantation. Gut Liver 5, 133\u2013142 (2011).","journal-title":"Gut Liver"},{"key":"50023_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00270-009-9619-2","volume":"33","author":"AM Moreira","year":"2010","unstructured":"Moreira, A. M. et al. Long-term results of percutaneous bilioenteric anastomotic stricture treatment in liver-transplanted children. Cardiovasc. Intervent. Radiol. 33, 90\u201396 (2010).","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"50023_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.139.10.1101","volume":"139","author":"Y. Ben Qian","year":"2004","unstructured":"Qian, Y. Ben., Liu, C. L., Lo, C. M. & Fan, S. T. Risk factors for biliary complications after liver transplantation. Arch. Surg. 139, 1101 (2004).","journal-title":"Arch. Surg."},{"key":"50023_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jpedsurg.2011.10.009","volume":"47","author":"ACA Tannuri","year":"2012","unstructured":"Tannuri, A. C. A. et al. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations. J. Pediatr. Surg. 47, 513\u2013522 (2012).","journal-title":"J. Pediatr. Surg."},{"key":"50023_CR22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1590\/1414-431X20143679","volume":"47","author":"JO Gon\u00e7alves","year":"2014","unstructured":"Gon\u00e7alves, J. O., Tannuri, A. C. A., Coelho, M. C. M., Bendit, I. & Tannuri, U. Dynamic expression of desmin, \u03b1-SMA and TGF-\u03b21 during hepatic fibrogenesis induced by selective bile duct ligation in young rats. Braz. J. Med. Biol. Res. 47, 850\u2013857 (2014).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"50023_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-025-04272-x","author":"JO Gon\u00e7alves","year":"2025","unstructured":"Gon\u00e7alves, J. O. et al. Key genes and histopathological alterations in hepatic fibrogenesis after segmental cholestasis in weaned rats. Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-025-04272-x (2025).","journal-title":"Pediatr. Res."},{"key":"50023_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3345\/cep.2022.00367","volume":"66","author":"E Ozdogan","year":"2023","unstructured":"Ozdogan, E. & Arikan, C. Liver fibrosis in children: A comprehensive review of mechanisms, diagnosis, and therapy. Clin. Exp. Pediatr. 66, 110\u2013124 (2023).","journal-title":"Clin. Exp. Pediatr."},{"key":"50023_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bbrc.2006.09.069","volume":"350","author":"C Zhao","year":"2006","unstructured":"Zhao, C. et al. PPAR\u03b3 agonists prevent TGF\u03b21\/Smad3-signaling in human hepatic stellate cells. Biochem. Biophys. Res. Commun. 350, 385\u2013391 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"50023_CR26","doi-asserted-by":"publisher","first-page":"G902","DOI":"10.1152\/ajpgi.00124.2006","volume":"291","author":"L Yang","year":"2006","unstructured":"Yang, L. et al. Regulation of peroxisome proliferator-activated receptor-\u03b3 in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G902\u2013G911 (2006).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"50023_CR27","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.2147\/DDDT.S524893","volume":"19","author":"Z Zhou","year":"2025","unstructured":"Zhou, Z. et al. Therapeutic targeting of PPAR\u03b3 in nonalcoholic fatty liver disease: Efficacy, safety, and drug development. Drug Des. Devel. Ther. 19, 7293\u20137319 (2025).","journal-title":"Drug Des. Devel. Ther."},{"key":"50023_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107245","volume":"205","author":"I Fuster-Mart\u00ednez","year":"2024","unstructured":"Fuster-Mart\u00ednez, I. & Calatayud, S. The current landscape of antifibrotic therapy across different organs: A systematic approach. Pharmacol. Res. 205, 107245 (2024).","journal-title":"Pharmacol. Res."},{"key":"50023_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-pharmtox-020524-012013","volume":"65","author":"H Gilgenkrantz","year":"2025","unstructured":"Gilgenkrantz, H., Sayegh, R. . Al. & Lotersztajn, S. Immunoregulation of liver fibrosis: New opportunities for antifibrotic therapy. Annu. Rev. Pharmacol. Toxicol. 65, 281\u2013299 (2025).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"50023_CR30","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gut.2005.079194","volume":"55","author":"IA Leclercq","year":"2006","unstructured":"Leclercq, I. A. Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats. Gut 55, 1020\u20131029 (2006).","journal-title":"Gut"},{"key":"50023_CR31","first-page":"4931","volume":"11","author":"F Marra","year":"2005","unstructured":"Marra, F. et al. Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. World J. Gastroenterol. 11, 4931\u20138 (2005).","journal-title":"World J. Gastroenterol."},{"key":"50023_CR32","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.bbrc.2019.09.084","volume":"519","author":"Z Wei","year":"2019","unstructured":"Wei, Z. et al. Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-\u03baB-TNF-\u03b1 signaling pathway in a PPAR\u03b3-dependent manner. Biochem. Biophys. Res. Commun. 519, 854\u2013860 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"50023_CR33","first-page":"1431","volume":"20","author":"A Ghasemi","year":"2021","unstructured":"Ghasemi, A., Jeddi, S. & Kashfi, K. The laboratory rat: age and body weight matter. EXCLI J. 20, 1431\u20131445 (2021).","journal-title":"EXCLI J."},{"key":"50023_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1507\/endocrj.47.21","volume":"47","author":"M Kimura","year":"2000","unstructured":"Kimura, M. et al. Thiazolidinediones exert difterent effects on insulin resistance between dexamethasone-treated rats and wistar fatty rats. Endocr. J. 47, 21\u201328 (2000).","journal-title":"Endocr. J."},{"key":"50023_CR35","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1053\/j.gastro.2003.12.008","volume":"126","author":"K Tomita","year":"2004","unstructured":"Tomita, K. et al. Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Gastroenterology 126, 873\u2013885 (2004).","journal-title":"Gastroenterology"},{"key":"50023_CR36","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/1440-1681.12020","volume":"39","author":"W Zhang","year":"2012","unstructured":"Zhang, W. et al. Thiazolidinediones improve hepatic fibrosis in rats with non\u2010alcoholic steatohepatitis by activating the adenosine monophosphate\u2010activated protein kinase signalling pathway. Clin. Exp. Pharmacol. Physiol. 39, 1026\u20131033 (2012).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"50023_CR37","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.6050","volume":"95","author":"P Georgiev","year":"2008","unstructured":"Georgiev, P. et al. Characterization of time-related changes after experimental bile duct ligation. Br. J. Surg. 95, 646\u2013656 (2008).","journal-title":"Br. J. Surg."},{"key":"50023_CR38","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1021\/ac60205a053","volume":"35","author":"I Bergman","year":"1963","unstructured":"Bergman, I. & Loxley, R. Two improved and simplified methods for the spectrophotometric determination of Hydroxyproline. Anal. Chem. 35, 1961\u20131965 (1963).","journal-title":"Anal. Chem."},{"key":"50023_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10142-023-01055-7","volume":"23","author":"F Xie","year":"2023","unstructured":"Xie, F., Wang, J. & Zhang, B. RefFinder: A web-based tool for comprehensively analyzing and identifying reference genes. Funct. Integr. Genomics 23, 125 (2023).","journal-title":"Funct. Integr. Genomics"},{"key":"50023_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u20138 (2001).","journal-title":"Methods"},{"key":"50023_CR41","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"50023_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"50023_CR43","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"50023_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020696","volume":"26","author":"Y Hu","year":"2025","unstructured":"Hu, Y. et al. In vivo and in vitro models of hepatic fibrosis for pharmacodynamic evaluation and pathology exploration. Int. J. Mol. Sci. 26, 696 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"50023_CR45","doi-asserted-by":"publisher","first-page":"35715","DOI":"10.1074\/jbc.M006577200","volume":"275","author":"T Miyahara","year":"2000","unstructured":"Miyahara, T. et al. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J. Biol. Chem. 275, 35715\u201335722 (2000).","journal-title":"J. Biol. Chem."},{"key":"50023_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.toxlet.2009.01.019","volume":"187","author":"F-M Suk","year":"2009","unstructured":"Suk, F.-M. et al. 15-Deoxy-\u039412,14-prostaglandin J2 inhibits fibrogenic response in human hepatoma cells. Toxicol. Lett. 187, 22\u201327 (2009).","journal-title":"Toxicol. Lett."},{"key":"50023_CR47","doi-asserted-by":"publisher","first-page":"6873","DOI":"10.1021\/jf402082g","volume":"61","author":"W-H Hsu","year":"2013","unstructured":"Hsu, W.-H., Lee, B.-H., Hsu, Y.-W. & Pan, T.-M. Peroxisome proliferator-activated receptor-\u03b3 activators monascin and rosiglitazone attenuate carboxymethyllysine-induced fibrosis in hepatic stellate cells through regulating the oxidative stress pathway but independent of the receptor for advanced glycat. J. Agric. Food Chem. 61, 6873\u20136879 (2013).","journal-title":"J. Agric. Food Chem."},{"key":"50023_CR48","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/labinvest.2008.20","volume":"88","author":"J Lin","year":"2008","unstructured":"Lin, J. & Chen, A. Activation of peroxisome proliferator-activated receptor-\u03b3 by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells. Lab. Investig. 88, 529\u2013540 (2008).","journal-title":"Lab. Investig."},{"key":"50023_CR49","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fimmu.2018.00893","volume":"9","author":"M Heming","year":"2018","unstructured":"Heming, M. et al. Peroxisome proliferator-activated receptor-\u03b3 modulates the response of macrophages to lipopolysaccharide and glucocorticoids. Front. Immunol. 9, 893 (2018).","journal-title":"Front. Immunol."},{"key":"50023_CR50","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/hep.28000","volume":"62","author":"R Scirpo","year":"2015","unstructured":"Scirpo, R. et al. Stimulation of nuclear receptor peroxisome proliferator\u2013activated receptor-\u03b3 limits NF-\u03baB-dependent inflammation in mouse cystic fibrosis biliary epithelium. Hepatology 62, 1551\u20131562 (2015).","journal-title":"Hepatology"},{"key":"50023_CR51","doi-asserted-by":"publisher","first-page":"16572","DOI":"10.1074\/jbc.RA118.003161","volume":"293","author":"Q Yao","year":"2018","unstructured":"Yao, Q. et al. Peroxisome proliferator\u2013activated receptor \u03b3 (PPAR\u03b3) induces the gene expression of integrin \u03b1V\u03b25 to promote macrophage M2 polarization. J. Biol. Chem. 293, 16572\u201316582 (2018).","journal-title":"J. Biol. Chem."},{"key":"50023_CR52","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1567-5769(01)00015-7","volume":"1","author":"P Wang","year":"2001","unstructured":"Wang, P. et al. Inhibition of the transcription factors AP-1 and NF-\u03baB in CD4 T cells by peroxisome proliferator-activated receptor \u03b3 ligands. Int. Immunopharmacol. 1, 803\u2013812 (2001).","journal-title":"Int. Immunopharmacol."},{"key":"50023_CR53","doi-asserted-by":"publisher","first-page":"E174","DOI":"10.1152\/ajpendo.90632.2008","volume":"297","author":"AHV Remels","year":"2009","unstructured":"Remels, A. H. V. et al. PPAR\u03b3 inhibits NF-\u03baB-dependent transcriptional activation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 297, E174\u2013E183 (2009).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"50023_CR54","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.tips.2015.06.010","volume":"36","author":"S Sauer","year":"2015","unstructured":"Sauer, S. Ligands for the nuclear peroxisome proliferator-activated receptor gamma. Trends Pharmacol. Sci. 36, 688\u2013704 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"50023_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32575-8","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice. Nat. Commun. 13, 5111 (2022).","journal-title":"Nat. Commun."},{"key":"50023_CR56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","volume":"16","author":"JM Banales","year":"2019","unstructured":"Banales, J. M. et al. Cholangiocyte pathobiology. Nat. Rev. Gastroenterol. Hepatol. 16, 269\u2013281 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"50023_CR57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/hep.21308","volume":"44","author":"G Szabo","year":"2006","unstructured":"Szabo, G., Dolganiuc, A. & Mandrekar, P. Pattern recognition receptors: A contemporary view on liver diseases. Hepatology 44, 287\u2013298 (2006).","journal-title":"Hepatology"},{"key":"50023_CR58","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3727\/105221616X692568","volume":"17","author":"C Hall","year":"2017","unstructured":"Hall, C. et al. Regulators of cholangiocyte proliferation. Gene Expr. 17, 155\u2013171 (2017).","journal-title":"Gene Expr."},{"key":"50023_CR59","first-page":"27","volume":"1","author":"A Franchitto","year":"2013","unstructured":"Franchitto, A. et al. Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology. Ann. Transl. Med. 1, 27 (2013).","journal-title":"Ann. Transl. Med."},{"key":"50023_CR60","doi-asserted-by":"publisher","first-page":"36703","DOI":"10.1074\/jbc.M004045200","volume":"275","author":"P Gervois","year":"2000","unstructured":"Gervois, P., Fruchart, J.-C., Delerive, P. & Staels, B. Induction of I\u03baB\u03b1 expression as a mechanism contributing to the anti-inflammatory activities of Peroxisome Proliferator-activated Receptor-\u03b1 activators. J. Biol. Chem. 275, 36703\u201336707 (2000).","journal-title":"J. Biol. Chem."},{"key":"50023_CR61","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s10753-021-01586-w","volume":"45","author":"Z Ma","year":"2022","unstructured":"Ma, Z. et al. Resveratrol alleviates hepatic fibrosis in associated with decreased Endoplasmic Reticulum stress-mediated apoptosis and inflammation. Inflammation 45, 812\u2013823 (2022).","journal-title":"Inflammation"},{"key":"50023_CR62","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.livres.2018.09.008","volume":"2","author":"Y-JY Wan","year":"2018","unstructured":"Wan, Y.-J.Y. & Sheng, L. Regulation of bile acid receptor activity. Liver Res. 2, 180\u2013185 (2018).","journal-title":"Liver Res."},{"key":"50023_CR63","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","volume":"5","author":"L Ding","year":"2015","unstructured":"Ding, L., Yang, L., Wang, Z. & Huang, W. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm. Sin. B 5, 135\u2013144 (2015).","journal-title":"Acta Pharm. Sin. B"},{"key":"50023_CR64","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/hep.24525","volume":"54","author":"Y-D Wang","year":"2011","unstructured":"Wang, Y.-D., Chen, W.-D., Yu, D., Forman, B. M. & Huang, W. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-\u03baB) in mice. Hepatology 54, 1421\u20131432 (2011).","journal-title":"Hepatology"},{"key":"50023_CR65","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","volume":"50","author":"JYL Chiang","year":"2009","unstructured":"Chiang, J. Y. L. Bile acids: Regulation of synthesis. J. Lipid Res. 50, 1955\u20131966 (2009).","journal-title":"J. Lipid Res."},{"key":"50023_CR66","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman, J. S. & Kumar, S. Bile acid metabolism and signaling in health and disease: Molecular mechanisms and therapeutic targets. Signal Transduct. Target. Ther. 9, 97 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"50023_CR67","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00109-021-02113-y","volume":"99","author":"S Bolourani","year":"2021","unstructured":"Bolourani, S., Brenner, M. & Wang, P. The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis. J. Mol. Med. 99, 1373\u20131384 (2021).","journal-title":"J. Mol. Med."},{"key":"50023_CR68","doi-asserted-by":"publisher","first-page":"803037","DOI":"10.3389\/fimmu.2021.803037","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Macrophage polarization and its role in liver disease. Front Immunol. 12, 803037 (2021).","journal-title":"Front Immunol."},{"key":"50023_CR69","doi-asserted-by":"publisher","unstructured":"Cui, N., Hu, M. & Khalil, R. A. Biochemical and Biological Attributes of Matrix Metalloproteinases. In 1\u201373 https:\/\/doi.org\/10.1016\/bs.pmbts.2017.02.005. (2017)","DOI":"10.1016\/bs.pmbts.2017.02.005"},{"key":"50023_CR70","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s12864-018-5211-y","volume":"19","author":"K Szo\u0142tysek","year":"2018","unstructured":"Szo\u0142tysek, K. et al. RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-\u03baB and p53 transcription factors in cells exposed to high doses of ionizing radiation. BMC Genomics 19, 813 (2018).","journal-title":"BMC Genomics"},{"key":"50023_CR71","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1242\/jcs.114.1.131","volume":"114","author":"Y-P Han","year":"2001","unstructured":"Han, Y.-P., Tuan, T.-L., Wu, H., Hughes, M. & Garner, W. L. TNF-\u03b1 stimulates activation of pro-MMP2 in human skin through NF-\u03baB mediated induction of MT1-MMP. J. Cell Sci. 114, 131\u2013139 (2001).","journal-title":"J. Cell Sci."},{"key":"50023_CR72","doi-asserted-by":"publisher","first-page":"33167","DOI":"10.1074\/jbc.M111.256644","volume":"286","author":"K Zarrabi","year":"2011","unstructured":"Zarrabi, K. et al. Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. J. Biol. Chem. 286, 33167\u201333177 (2011).","journal-title":"J. Biol. Chem."},{"key":"50023_CR73","doi-asserted-by":"publisher","first-page":"13453","DOI":"10.1074\/jbc.270.22.13453","volume":"270","author":"ML Corcoran","year":"1995","unstructured":"Corcoran, M. L. & Stetler-Stevenson, W. G. Tissue Inhibitor of Metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J. Biol. Chem. 270, 13453\u201313459 (1995).","journal-title":"J. Biol. Chem."},{"key":"50023_CR74","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0014-5793(96)01066-6","volume":"396","author":"K Yamashita","year":"1996","unstructured":"Yamashita, K. et al. Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP\u20101 and TIMP\u20102). FEBS Lett. 396, 103\u2013107 (1996).","journal-title":"FEBS Lett."},{"key":"50023_CR75","doi-asserted-by":"publisher","first-page":"re6","DOI":"10.1126\/scisignal.127re6","volume":"1","author":"WG Stetler-Stevenson","year":"2008","unstructured":"Stetler-Stevenson, W. G. Tissue Inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci. Signal. 1, re6 (2008).","journal-title":"Sci. Signal."},{"key":"50023_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117826","volume":"183","author":"A Heldens","year":"2025","unstructured":"Heldens, A. et al. The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature. Biomed. Pharmacother. 183, 117826 (2025).","journal-title":"Biomed. Pharmacother."},{"key":"50023_CR77","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.bbagrm.2015.07.016","volume":"1849","author":"Y-J Chen","year":"2015","unstructured":"Chen, Y.-J. & Chang, L.-S. NF\u03baB- and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-\u03b1-treated human leukemia U937 cells. Biochim. Biophys. Acta Gene Regul. Mech. 1849, 1248\u20131259 (2015).","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"50023_CR78","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/cells7080096","volume":"7","author":"T Wang","year":"2018","unstructured":"Wang, T. et al. Association of NF-\u03baB and AP-1 with MMP-9 overexpression in 2-chloroethanol exposed rat astrocytes. Cells 7, 96 (2018).","journal-title":"Cells"},{"key":"50023_CR79","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1006\/bbrc.1999.1551","volume":"264","author":"M Bond","year":"1999","unstructured":"Bond, M., Baker, A. H. & Newby, A. C. Nuclear Factor \u03baB activity is essential for Matrix Metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. Biochem. Biophys. Res. Commun. 264, 561\u2013567 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"50023_CR80","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9065","author":"A Mitra","year":"2020","unstructured":"Mitra, A. An observational study of reduction in glycemic parameters and liver stiffness by saroglitazar 4 mg in patients with Type 2 diabetes mellitus and nonalcoholic fatty liver disease. Cureus https:\/\/doi.org\/10.7759\/cureus.9065 (2020).","journal-title":"Cureus"},{"key":"50023_CR81","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbrc.2004.01.038","volume":"315","author":"K Kawaguchi","year":"2004","unstructured":"Kawaguchi, K. et al. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet. Biochem. Biophys. Res. Commun. 315, 187\u2013195 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"50023_CR82","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4428","author":"J Glen","year":"2016","unstructured":"Glen, J., Floros, L., Day, C. & Pryke, R. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance. BMJ https:\/\/doi.org\/10.1136\/bmj.i4428 (2016).","journal-title":"BMJ"},{"key":"50023_CR83","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"T Wynn","year":"2008","unstructured":"Wynn, T. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199\u2013210 (2008).","journal-title":"J. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50023-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50023-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50023-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:05:08Z","timestamp":1781834708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50023-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50023"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50023-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"19160"}}